Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RECI | Milan | EUR | Real-time | |
RECm | BATS Europe | EUR | Delayed | |
0KBS | London | EUR | Real-time | |
RECI | Vienna | EUR | Real-time |
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing’s syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Name | Age | Since | Title |
---|---|---|---|
Michaela Castelli | 53 | 2014 | Lead Independent Director |
Andrea Recordati | 52 | 1998 | Non-Executive Chairman |
Ezio Maria Simonelli | 65 | 2020 | Statutory Auditor |
Livia Amidani Aliberti | 62 | 2014 | Statutory Auditor |
Luigi Felice La Corte | 54 | 2019 | Group CFO & Executive Director |
Cathrin Petty | 50 | 2018 | Executive Director |
Antonio Santi | 46 | 2017 | Chairman of Statutory Auditor Board |
Elisa Corghi | 51 | 2022 | Independent Director |
Guido Guidi | 70 | 2020 | Non-Executive Vice Chairman |
Kim Stratton | 61 | 2021 | Non-Executive Director |
Giampiero Mazza | 54 | 2018 | Executive Director |
Giorgio De Palma | 49 | 2020 | Executive Director |
Piergiorgio Peluso | 55 | 2020 | Independent Non-Executive Director |
Joanna Susan Le Couilliard | 60 | 2019 | Independent Non-Executive Director |
Robert Koremans | 61 | 2021 | CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review